Skip to main content

GE & Partners Announce Winners Of the First Stage of $100M "HEALTHYMAGINATION CANCER CHALLENGE"

General Electric announced today five innovation award winners as part  of the first stage of its $100 million "GE healthymagination Cancer Challenge." More than 500 ideas from 40 countries were submitted, sparking robust conversations among more than 200 academic institutions and  researchers on the Challenge's open innovation platform.

The five innovation award winners have the potential to help doctors find cancer earlier, make more accurate diagnoses and choose the best possible treatment based on each patient's unique cancer. The submitted  ideas include ones that could help doctors better understand the molecular similarities between breast cancer and other solid tumors with a particular focus on tumors associated with triple negative cancer, a type of  cancer that is less responsive to standard treatments and is typically more aggressive. GE is committed to a  new approach at healthymagination that shines a spotlight on early-stage ideas to accelerate the researchers' work and ultimately help patients sooner.

Beth Comstock, senior vice president and chief marketing officer, GE said, "We launched the Challenge as a call to action for oncology researchers, businesses, and other innovators around the world to accelerate  innovation and help stop this deadly disease. It is often challenging for early stage research to grab the attention of seed investors. The Challenge has shown us that there are a remarkable number of breakthrough ideas out there that deserve promotion, investment and incubation."

In addition to the $100,000 seed award, GE will provide support for each winner through mentorship and  access to GE researchers and industry thought leaders with opportunity for expanded partnerships in the  future. "GE and Clarient focus on helping health providers understand and define the drivers of a patient's  particular cancer. The Challenge winners' work will change the future of fighting cancer," said Carrie Eglinton-Manner, general manager of Clarient, the cancer diagnostics company acquired by GE in 2010.

"In addition  to the grant money, we will help mentor, develop and accelerate the growth of these winning ideas."

The winners were selected by a panel of judges that included venture capital partners, GE executives, and several leading healthcare luminaries including former U.S. FDA Commissioner and National Cancer Institute  Director, Dr. Andrew Von Eschenbach; Professor of Surgery and Director of the University of Michigan Breast  Care Center, Dr. Lisa Newman; and cancer medicine specialist and Imperial College's professor of cancer medicine, Dr. Justin Stebbing.

The five innovation Challenge award winners are:
  • MyCancerGenome- Personalized Approach to Triple Negative Breast Cancer: Vanderbilt University is developing MyCancerGenome, a free online cancer medicine resource and decision-making tool for physicians, patients, caregivers and researchers. It provides up-to-date information on what mutations make breast cancer grow and related treatment implications, including available genome- directed clinical trials for triple negative breast cancer.

  • Creating Safer & Stronger Breast Implants with Cancer-fighting and Healing Properties: The University of Akron is developing new materials for breast reconstruction to transform tissue expanders and implants into cancer-fighting and healing devices. Using coatings embedded with pharmaceutical agents the new device is expected to help fight infection, reduce inflammation, and possibly even target and destroy stray cancer cells.
  • Identifying a Predisposition to Cancer Spread: Moffitt Cancer Center is working to understand the genetic "modifier" genes and their role in predisposition to the spread of cancer to other parts of the body following cancer onset. This research could form the basis of diagnostic testing for genes that place a patient at disproportionate risk for cancer spread and guide aggressiveness of treatment.

  • Saving Lives in Developing Countries: For developing countries such as Uganda, breast ultrasound holds promise in identifying cancers in young women with palpable lumps. Fred Hutchinson Cancer Research Center and Uganda Cancer Institute (UCI) in Kampala are establishing a breast cancer screening program where women will receive education about breast cancer and those with symptoms will be offered clinical breast exam and breast ultrasound. Women with suspicious lumps will be referred to the UCI for tissue sampling and, if malignancy is diagnosed, treatment.

  • Moving to Personalized Therapy for Triple Negative Breast Cancer: Researchers at Vanderbilt- Ingram Cancer Center have demonstrated that gene expression analysis reveals at least six distinct disease subtypes for triple negative breast cancer that likely respond differently to chemotherapy. Using this discovery, the Center is designing clinical trials with targeted therapy for select subtypes which will soon be offered to patients.

Information on the winners is available at www.healthymagination.com.

Comments

Popular posts from this blog

Howard Hires Hannah-Jones

  Nikole Hannah-Jones reminds us all why HBCUs were created in the first place. (July 7, 2021) -  Howard University offered an olive branch to Jones when her own alma mater, the University of North Carolina, chose not to offer this great talent in journalism a tenured professor position. [ Alumus Ta-Nahisi Coates  joins Howard roster] ICYMI, Jones is the creator of The 1619 Project, a documentary that chronicles the early institution of slavery and its role in shaping the Americas we know today. Source: The 1619 Project by Nikole Hannah-Jones. The Project has garnered both acceptance and criticism. Those who support the vision understand that the truths about slavery have, throughout American history, been either whitewashed, or not taught at all, diminishing the roles and treatment of the African nations who built it. Slavery, in all fifty states (including the ‘stateless’ District of Columbia) built an economic powerhouse infrastructure that caused the United State...

DC Affordable Housing Realized?

 From the Office of DC Mayor, Muriel Bowser (Washington, DC) – Today, Mayor Muriel Bowser celebrated the opening of the Todd A. Lee Senior Residences at Kennedy Street, a 38-unit, all-affordable senior community located in the Brightwood Park neighborhood of Ward 4. All 38 apartments are for residents who are 55 or older and earn no more than 50 percent of the area median income. “The Todd A. Lee Senior Residences embody our DC values and represent the importance of having safe and affordable homes for our seniors to age in place, in the communities they know and love,” said Mayor Bowser. “Todd’s legacy will live on through the many families he helped stay in DC, through the innovative programs he created, and now through these beautiful homes for our seniors.” The Todd A. Lee Senior Residences are a result of a solicitation to transform vacant land into affordable housing by the DC Department of Housing and Community Development (DHCD) who also provided a $7.4 million loan from th...

First Family Attends Zion Baptist Church

The First Family attended the historic Zion Baptist Church today in honor of the Martin Luther King, Jr. holiday. The church was founded in 1864 by African Americans who migrated to Washington from Fredericksburg, VA and is currently pastored by Rev. Keith Byrd, Sr. who employed the congregation today to "be a source of hope." Dr. King's 'Letter From a Birmingham Jai l' was recited to the parishoners while the Sunday program featured a picture of Dr. King on the cover along with the words "I Have A Dream". The First Family attending church service Sunday at Zion Baptist Church.  Official White House photo. The First Family is known to visit area DC churches.  Churches the First Family have visited in our area include the 19th Street Baptist Church, Allen Chapel A.M.E., Metropolitan A.M.E. Church, Shiloh Baptist, the National Cathedral,  St. John's Episcopal Church, and Evergreen Chapel at Camp David.